Karachi, Citi Pharma Ltd. (CPHL), since its 2021 entry into the stock market, announced a 25% dividend for 2024, marking its first distribution since listing. The company posted an earnings per share (EPS) of Rs. 2.88 for January-February 2024, showcasing its upward trajectory in the pharmaceutical sector. With a daily weighted average rate of Rs. 23.31 and a peak of Rs. 25.69, Citi Pharma is rapidly establishing itself as a significant player. The firm, committed to innovation and quality in healthcare, offers a market lot size of 1 unit to its investors.